Article: Economic evaluation of point-of-care testing in the remote primary health care setting of Australia's Northern Territory

Aim: To determine the cost-effectiveness of utilizing point-of-care testing (POCT) on the Abbott i-STAT device as a support tool to aid decisions regarding the emergency medical retrievals of patients at remote health centers in the Northern Territory (NT) of Australia.

Methods: A decision analytic simulation model-based economic evaluation was conducted using data from patients presenting with three common acute conditions (chest pain, chronic renal failure due to missed dialysis session(s), and acute diarrhea) at six remote NT health centers from July to December 2015. The specific outcomes measured in this study were the number of unnecessary emergency medical retrieval prevented through POCT. Cost savings through prevented unnecessary medical retrievals for each presentation type were then determined and extrapolated to give per annum NT-wide estimates.

Results: POCT prevented 60 unnecessary medical evacuations from a total of 200 patient cases meeting the selection criteria (48/147 for chest pain, 10/28 for missed dialysis, and 2/25 for acute diarrhea). The associated cost savings were AUD $4,674, $8,034, and $786 per patient translating to NT-wide savings of AUD $13.72 million, $6.45 million, and $1.57 million per annum (AUD $21.75 million in total) for chest pain, missed dialysis, and acute diarrhea presentations, respectively.

Conclusion: This study demonstrated that POCT when used to aid decision making for acutely ill patients delivered significant cost savings for the NT health care system by preventing unnecessary emergency medical retrievals.

Citing Articles

Regulation and governance for the implementation and management of point-of-care testing in Australia: a scoping review.

Prestedge J, Kaufman C, Williamson D BMC Public Health. 2025; 25(1):758.

PMID: 39994584 PMC: 11849271. DOI: 10.1186/s12889-025-21894-2.

Quantitative determination of leptin hormone using gold nanoparticle-based lateral flow assay.

Zor E, Alpaydin S, Bingol H Mikrochim Acta. 2025; 192(2):63.

PMID: 39789177 PMC: 11717784. DOI: 10.1007/s00604-024-06945-6.

Co-creation process of an intervention to implement a multiparameter point-of-care testing device in a primary healthcare setting for non-communicable diseases in Peru.

Albitres-Flores L, Perez-Leon S, Bernabe-Ortiz A, Tenorio-Mucha J, Cardenas M, Vetter B BMC Health Serv Res. 2024; 24(1):401.

PMID: 38553724 PMC: 10981306. DOI: 10.1186/s12913-024-10809-3.

Successes and challenges of primary health care in Australia: A scoping review and comparative analysis.

Mengistu T, Khatri R, Erku D, Assefa Y J Glob Health. 2023; 13:04043.

PMID: 37387471 PMC: 10311945. DOI: 10.7189/jogh.13.04043.

Leading POCT Networks: Operating POCT Programs Across Multiple Sites Involving Vast Geographical Areas and Rural Communities.

Randell E, Thakur V EJIFCC. 2021; 32(2):179-189.

PMID: 34421486 PMC: 8343053.

References

1.

Shephard M, Spaeth B, Mazzachi B, Auld M, Schatz S, Loudon J . Design, implementation and initial assessment of the Northern Territory Point-of-Care Testing Program. Aust J Rural Health. 2012; 20(1):16-21. DOI: 10.1111/j.1440-1584.2011.01243.x. View

2.

Blattner K, Nixon G, Dovey S, Jaye C, Wigglesworth J . Changes in clinical practice and patient disposition following the introduction of point-of-care testing in a rural hospital. Health Policy. 2009; 96(1):7-12. DOI: 10.1016/j.healthpol.2009.12.002. View

3.

Quinn A, Dixon D, Meenan B . Barriers to hospital-based clinical adoption of point-of-care testing (POCT): A systematic narrative review. Crit Rev Clin Lab Sci. 2015; 53(1):1-12. DOI: 10.3109/10408363.2015.1054984. View

4.

Fenwick E, Claxton K, Sculpher M . Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001; 10(8):779-87. DOI: 10.1002/hec.635. View

5.

Barton P, Bryan S, Robinson S . Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy. 2004; 9(2):110-8. DOI: 10.1258/135581904322987535. View

6.

Howick J, Cals J, Jones C, Price C, Pluddemann A, Heneghan C . Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open. 2014; 4(8):e005611. PMC: 4127935. DOI: 10.1136/bmjopen-2014-005611. View

7.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R . Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004; 8(36):iii-iv, ix-xi, 1-158. DOI: 10.3310/hta8360. View

8.

John A, Price C . Economic Evidence and Point-of-Care Testing. Clin Biochem Rev. 2013; 34(2):61-74. PMC: 3799220. View

9.

Spaeth B, Shephard M, Schatz S . Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural Remote Health. 2014; 14(4):2849. View

10.

Laurence C, Moss J, Briggs N, Beilby J . The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial. BMC Health Serv Res. 2010; 10:165. PMC: 2905350. DOI: 10.1186/1472-6963-10-165. View

11.

OConnor T, Hanks H, Elcock M, Turner R, Veitch C . The medical and retrieval costs of road crashes in rural and remote northern Queensland, 2004-2007: findings from the Rural and Remote Road Safety Study. Med J Aust. 2009; 190(2):54-6. DOI: 10.5694/j.1326-5377.2009.tb02274.x. View

Economic Evaluation of Point-of-care Testing in the Remote Primary Health Care Setting of Australia's Northern Territory